Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Liabilities and Shareholders Equity (2016 - 2025)

Avanos Medical (AVNS) has disclosed Liabilities and Shareholders Equity for 13 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 6.97% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 billion through Dec 2025, down 30.04% year-over-year, with the annual reading at $1.1 billion for FY2025, 6.97% down from the prior year.
  • Liabilities and Shareholders Equity hit $1.1 billion in Q4 2025 for Avanos Medical, up from $1.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q4 2022 to a low of $1.0 billion in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $1.5 billion across 5 years, with a median of $1.7 billion in 2024.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 11.43% in 2022 and later plummeted 37.33% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $1.6 billion in 2021, then grew by 11.43% to $1.8 billion in 2022, then fell by 5.29% to $1.7 billion in 2023, then tumbled by 31.8% to $1.2 billion in 2024, then fell by 6.97% to $1.1 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for AVNS at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.0 billion in Q2 2025.